Integrating pharmacogenomics in three Middle Eastern countries' healthcare (Lebanon, Qatar, and Saudi Arabia): Current insights, challenges, and strategic directions.
<h4>Background and objectives</h4>Pharmacogenomics (PGx) leverages genomic information to tailor drug therapies, enhancing precision medicine. Despite global advancements, its implementation in Lebanon, Qatar, and Saudi Arabia faces unique challenges in clinical integration. This study a...
Saved in:
| Main Authors: | Said El Shamieh, Rimah Abdullah Saleem, Dalal Hammoudi Halat, Hana M A Fakhoury, Kholoud Bastaki, Mirna Fawaz, Ahmed Malki, Rajaa Fakhoury |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0319042 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinically actionable pharmacogenomic landscape of antidepressants and antipsychotics in Qatar: a population-based cohort study
by: Dinesh Velayutham, et al.
Published: (2025-01-01) -
Authoritarian States and Global Sport: The Contested Cases of Qatar, the UAE and Saudi Arabia
by: Jonathan Grix, et al.
Published: (2024-12-01) -
Novel Compounds for Hair Repair: Chemical Characterization and In Vitro Analysis of Thiol Cross-Linking Agents
by: Sami El Khatib, et al.
Published: (2025-04-01) -
Evaluation of vitamin D status, vitamin D receptor expression, and innate immune mediators in COVID-19
by: Ferdos Missilmani, et al.
Published: (2025-08-01) -
Pharmacogenomics and Pharmacometabolomics in Precision Tramadol Prescribing for Enhanced Pain Management: Evidence from QBB and EMR Data
by: Dhoha Dhieb, et al.
Published: (2025-06-01)